aceA genetic algorithm-optimized EWMA control chart integrating machine learning-based risk prediction for multistage thyroid cancer treatment monitoring
Effective monitoring of thyroid cancer treatment requires timely detection of clinically meaningful changes across complex, multistage care pathways. Traditional monitoring approaches often rely on static thresholds and periodic assessments, limiting their sensitivity to subtle yet important process deviations and potentially delaying clinical intervention. This study aimed to develop and evaluate an integrated, data-driven framework that combines deep learning-based risk prediction with genetic algorithm-optimi…
Combining a neural network risk predictor with genetic algorithm-tuned EWMA charts detected clinically meaningful deviations in thyroid cancer treatment more reliably than non-optimized charts.
The source describes the framework as showing feasibility, and its use for continuous, adaptive monitoring depends on future integration with EMR systems, so real-world clinical impact is not yet shown.
Evidence
- Peer-reviewedPLOS One2026-10-06
How should this claim be treated?
Truvace Impact Record TRV-2026-1816, v1: “A genetic algorithm-optimized EWMA control chart integrating machine learning-based risk prediction for multistage thyroid cancer treatment monitoring.” Truvace, 2026-10-18. /record/TRV-2026-1816 (accessed at citation time). sha256 1a6531c9b639c5eb…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1816 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.